Organogenesis Holdings Inc. Class A Common Stock (ORGO) Earnings

ORGO Earnings Reports

Positive Surprise Ratio

ORGO beat 20 of 30 last estimates.

67%

Next Report

Next Week

Date of Next Report

Nov 05, 2026

Estimate for Q3 26 (Revenue/ EPS)

$53.14M

-$0.17

Implied change from Q2 26 (Revenue/ EPS)

+21.45%

-76.71%

Implied change from Q3 25 (Revenue/ EPS)

-64.77%

-213.33%

Organogenesis Holdings Inc. Class A Common Stock earnings per share and revenue

On Aug 06, 2026, ORGO reported earnings of -0.73 USD per share (EPS) for Q2 26, missing the estimate of -0.35 USD, resulting in a -104.48% surprise. Revenue reached 43.76 million, compared to an expected 55.34 million, with a -20.93% difference. The market reacted with a -22.82% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.17 USD, with revenue projected to reach 53.14 million USD, implying an decrease of -76.71% EPS, and increase of 21.45% in Revenue from the last quarter.

FAQ

What were Organogenesis Holdings Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Organogenesis Holdings Inc. Class A Common Stock reported EPS of -$0.73, missing estimates by -104.48%, and revenue of $43.76M, -20.93% below expectations.

How did the market react to Organogenesis Holdings Inc. Class A Common Stock's Q2 2026 earnings?

The stock price moved down -22.82%, changed from $2.41 before the earnings release to $1.86 the day after.

When is Organogenesis Holdings Inc. Class A Common Stock expected to report next?

The next earning report is scheduled for Nov 05, 2026.

What are the forecasts for Organogenesis Holdings Inc. Class A Common Stock's next earnings report?

Based on 4 analysts, Organogenesis Holdings Inc. Class A Common Stock is expected to report EPS of -$0.17 and revenue of $53.14M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.